Cutaneous angiosarcoma presenting as an unusual facial bruise

Age and Ageing

Volumn 33, Issue 5, 2004, Pages 512-514

  Rich, Anna L ^a   Berman, Peter ^b  

^a DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Angiosarcoma; Elderly; Facial bruising; Rash; Sarcoma

Indexed keywords

ATORVASTATIN; CLOPIDOGREL;

AGED; ANGIOSARCOMA; ARTICLE; BLOOD CLOTTING; CANCER INVASION; CANCER MORTALITY; CASE REPORT; CEREBELLUM INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIET THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FACE INJURY; FEMALE; GENERAL PRACTICE; HUMAN; HYPERCHOLESTEROLEMIA; MEDICAL LITERATURE; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN BRUISING; SOFT TISSUE SARCOMA; SUBCUTANEOUS TISSUE; THROMBOCYTE COUNT; TUMOR BIOPSY; TUMOR GROWTH; VASCULAR TUMOR;

AGED; AGED, 80 AND OVER; BIOPSY; CONTUSIONS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FACIAL NEOPLASMS; FEMALE; HEMANGIOSARCOMA; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NOSE NEOPLASMS; SCALP; SKIN; SKIN NEOPLASMS;

EID: 4544253667     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afh171     Document Type: Article

References (13)

1. Mentzel T, Kutzner H, Wollina U. Cutaneous angiosarcoma of the face: clinicopathologic and immunohistochemical study of a case resembling rosacea clinically. J Am Acad Dermatol 1998; 38: 837-40.
2. Lydiatt WM, Shaha AR, Shah JP. Angiosarcoma of the head and neck. Am J Surg 1994; 168: 451-4.
3. Aust MR, Olsen KD, Lewis JE et al. Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otol Rhinol Laryngol 1997; 106: 943-51.
4. Mark RJ, Tran LM, Sercarz J, Fu YS, Calcaterra TC, Juillard GF. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993; 119: 973-85.
5. Verweij J, Mouridsen HT, Nielssen OS et al. The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view. Crit Rev Oncol Hematol 1995; 20: 193-201.
6. Santoro A, Tursz T, Mouridsen H et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995; 13: 1537-45.
7. Wollina U, Fuller J, Graefe T, Kaattz M, Lopatta E. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy. J Cancer Res Clin Oncol 2001; 127: 396-9.
8. Lankester KJ, Brown RS, Spittle MF. Complete resolution of angiosarcoma of the scalp with liposomal daunorubicin and radiotherapy. Clin Oncol (R Coll Radiol) 1999; 11: 208-10.
9. Ulrich L, Krause M, Brachmann A, Franke I, Gollnick H. Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation. J Eur Acad Dermatol Venereol 2000; 14: 412-5.
10. Fakih MG, Defrances MC, Ohori NP, Ramanathan RK. Unusual tumors involving the head and neck region: Case 1. Angiosarcoma of the scalp. J Clin Oncol 2001; 19: 4173-4.
11. Fata F, O'Reilly E, Ilson D et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86: 2034-7.
12. Mauro MJ, O'Dwyer M, Heinrich MC, Druker BJ. STI571: a paradigm of new agents for cancer therapeutics. J Clin Oncol 2002; 20: 325-34.
13. Arbiser JL, Larsson H, Claesson-Welsh L et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol 2000; 156: 1469-76.